Nilesh P. Kumar
Avinashi Road
Coimbatore, TN, India
Coimbatore, TN, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications
Aflibercept vs ranibizumab biosimilars: manufacturing differences that might matter in the long run.
Aflibercept vs ranibizumab biosimilars: manufacturing differences that might matter in the long run.
Journal: Eye (London, England)
Published: July 23, 2025
The conundrum of abundance: challenges of having too many biosimilars.
Journal: Expert opinion on biological therapy
Published: May 13, 2025
Biosimilar Ranibizumab (Ranieyes) Safety and Efficacy in the Real World: BRESER Study.
Journal: Journal of vitreoretinal diseases
Published: March 03, 2025
Aflibercept 2 mg biosimilars-will they lead the Anti-VEGF biosimilar world globally.
Journal: Eye (London, England)
Published: January 30, 2025
Global experience of faricimab in clinical settings - a review.
Journal: Expert opinion on biological therapy
Published: March 29, 2024
Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI).
Journal: Eye (London, England)
Published: February 01, 2024
Biosimilar ranibizumab in India- overview of phase 3 clinical trial designs.
Journal: Eye (London, England)
Published: January 05, 2024
Biosimilar to Biosimilar Anti-VEGF Switching for Retinal Diseases.
Journal: Journal of vitreoretinal diseases
Published: November 17, 2023
Subfoveal neurosensory detachment flattening and observe (SNF-Ob) approach for the management of Ci-DMO - a multicentric study.
Journal: Eye (London, England)
Published: October 18, 2023
Aflibercept biosimilars - update on the development progress.
Journal: Eye (London, England)
Published: October 16, 2023
Preparing for the next decade of anti-VEGF biosimilars for retinal diseases: a focus on South Asia.
Journal: Expert opinion on biological therapy
Published: July 20, 2023
Biosimilar anti-VEGF- is prefilled syringe (PFS) a challenge?
Journal: Eye (London, England)
Published: July 07, 2023
Last Updated: 09/26/2026